A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs
出版年份 2021 全文链接
标题
A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2021-04-29
DOI
10.1080/14740338.2021.1924147
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting
- (2021) S. Ribero et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Evidence for a “window of opportunity” in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicenter cohort study
- (2020) A.V. Marzano et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa
- (2020) Vassiliki Tzanetakou et al. Expert Opinion On Drug Safety
- A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
- (2020) Alice Gottlieb et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Effect of Subcutaneous Brodalumab upon Clinical Disease Activity in Hidradenitis Suppurativa: An Open Label Cohort Study
- (2020) John W. Frew et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
- (2020) Zachary E. Holcomb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results
- (2020) Akimichi Morita et al. JOURNAL OF DERMATOLOGY
- Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis
- (2019) Leah Ellis Wells et al. PEDIATRIC DERMATOLOGY
- Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa
- (2019) L. Prussick et al. BRITISH JOURNAL OF DERMATOLOGY
- Determining the Optimal Dose of Infliximab for Treatment of Hidradenitis Suppurativa
- (2019) Ashley N. Oskardmay et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective
- (2019) Youwei Bi et al. AAPS Journal
- Biologics exposure during pregnancy and breastfeeding in a psoriasis patient
- (2019) Cristina Mugheddu et al. Dermatologic Therapy
- Long‐term therapy with anakinra in hidradenitis suppurativa in three patients
- (2019) Raphaël André et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa
- (2019) Akimichi Morita et al. JOURNAL OF DERMATOLOGY
- Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
- (2019) Gerd R. Burmester et al. ADVANCES IN THERAPY
- High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa
- (2019) Mondana H. Ghias et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease
- (2019) Jalal Maghfour et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials
- (2019) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study
- (2018) H Chiu et al. ACTA DERMATO-VENEREOLOGICA
- Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
- (2018) R. B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab
- (2018) Sze-Wen Ting et al. CLINICAL DRUG INVESTIGATION
- Secukinumab: A positive outcome in a patient with severe psoriasis and HBV-HCV co-infection
- (2018) Francesca Peccerillo et al. Dermatologic Therapy
- Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development
- (2018) Rebecca Matro et al. GASTROENTEROLOGY
- MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study
- (2018) Theodora Kanni et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
- (2018) Christos C. Zouboulis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Five successful pregnancies with antenatal anakinra exposure
- (2018) Chelsey J F Smith et al. RHEUMATOLOGY
- Successful use of secukinumab in a 4-year-old patient with deficiency of interleukin-36 antagonist
- (2018) Katharina Köstner et al. RHEUMATOLOGY
- Ustekinumab Exposure during Conception and Pregnancy in Patients with Chronic Plaque Psoriasis - a case series of 10 pregnancies
- (2018) N. Watson et al. BRITISH JOURNAL OF DERMATOLOGY
- Hormonal, Stem Cell and Notch Signaling as Possible Mechanisms of Disease in Hidradenitis Suppurativa: a Systems-Level Transcriptomic Analysis
- (2018) T. D. Gauntner BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C
- (2018) S.A.R. Siegel et al. BRITISH JOURNAL OF DERMATOLOGY
- Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs
- (2018) Toshiyuki Watanabe et al. International Journal of Rheumatic Diseases
- Guselkumab in the Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review
- (2018) Rachel G. Casseres et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guselkumab in the treatment of severe Hidradenitis suppurativa
- (2018) M Kovacs et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation
- (2017) Catherine R Rowan et al. Journal of Crohns & Colitis
- Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature
- (2017) Igor Snast et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
- (2017) S. Piaserico et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of secukinumab in hepatitis B virus
- (2017) S.L. Bevans et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors
- (2017) Taryn Youngstein et al. RHEUMATOLOGY
- Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
- (2017) Zheng Zhang et al. BMJ Open
- Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
- (2016) J.L. Blok et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety of secukinumab in the treatment of psoriasis
- (2016) Andrew Blauvelt Expert Opinion On Drug Safety
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS
- (2016) Stephanie M. Gallitano et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
- (2016) Peter C.M. van de Kerkhof et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab in Patients with Active Noninfectious Uveitis
- (2016) Glenn J. Jaffe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
- (2016) Vassiliki Tzanetakou et al. JAMA Dermatology
- Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study
- (2015) Corinna Weber-Schoendorfer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
- (2015) Joshua B. French et al. DRUG SAFETY
- HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
- (2015) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
- (2015) Robert E. Kalb et al. JAMA Dermatology
- Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
- (2014) A.B. Kimball et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
- (2014) Nabeel Khan et al. Expert Opinion On Drug Safety
- The prevalence of metabolic syndrome in patients with hidradenitis suppurativa
- (2014) Daniel A. Gold et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection
- (2014) H. Saeki et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis
- (2014) A. Alsenaid et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- TNF-α inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment
- (2014) Mihaela C. Micu et al. RHEUMATOLOGY
- Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
- (2013) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- (2013) Alexa B. Kimball et al. ANNALS OF INTERNAL MEDICINE
- The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
- (2013) H.-Y. Chiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa
- (2013) G.R. Vinding et al. BRITISH JOURNAL OF DERMATOLOGY
- An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa
- (2013) Kieron S. Leslie et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting
- (2012) R. Navarro et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
- (2012) Benjamin G. Vazquez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States
- (2012) Irene Cosmatos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Degree of TNF-α/IL-10 Cytokine Elevation Correlates With IVF Success Rates in Women Undergoing Treatment With Adalimumab (Humira) and IVIG
- (2011) Edward E. Winger et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
- (2011) I. Miller et al. BRITISH JOURNAL OF DERMATOLOGY
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab for the treatment of HIV psoriasis
- (2011) Vasileios Paparizos et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy
- (2011) Roberto Pérez-Alvarez et al. MEDICINE
- A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa
- (2010) Masahiro Amano et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy
- (2010) Monika Arenbergerova et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Blocking interleukin-1β in acute and chronic autoinflammatory diseases
- (2010) C. A. Dinarello JOURNAL OF INTERNAL MEDICINE
- Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
- (2010) Annika Grant et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- -Secretase Gene Mutations in Familial Acne Inversa
- (2010) B. Wang et al. SCIENCE
- Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?
- (2009) L Matusiak et al. ACTA DERMATO-VENEREOLOGICA
- Long-term Successful Adalimumab Therapy in Severe Hidradenitis Suppurativa
- (2009) Ricardo Blanco et al. ARCHIVES OF DERMATOLOGY
- ORIGINAL ARTICLE: Treatment with Adalimumab (Humira®) and Intravenous Immunoglobulin Improves Pregnancy Rates in Women Undergoing IVF*
- (2008) Edward E. Winger et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
- (2008) Jean E. Revuz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started